JKT Biopharma Co., Ltd.
2 clinical trials · Sponsor
◉ Watch JKT Biopharma Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| SHEN211 Tablets for the Treatment of Mild and Moderate Novel Corona Virus Infections (COVID-19) (NCT06288893) | JKT Biopharma Co., Ltd. | 2024-04-01 |
| The Safety, Tolerability, Pharmacokinetics and Food Effects of SHEN211 Tablet in Healthy Subjects (NCT06214858) | JKT Biopharma Co., Ltd. | 2023-12-14 |
Track JKT Biopharma Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.